Bank of New York Mellon Corp - KALVISTA PHARMACEUTICALS INC ownership

KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 65 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of KALVISTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$811,896
+8.9%
84,309
+1.8%
0.00%
Q2 2023$745,209
+14.2%
82,801
-0.3%
0.00%
Q1 2023$652,467
+16.3%
83,011
-0.0%
0.00%
Q4 2022$561,202
-53.3%
83,018
+0.3%
0.00%
Q3 2022$1,201,000
+67.0%
82,732
+13.1%
0.00%
Q2 2022$719,000
-29.9%
73,135
+5.1%
0.00%
Q1 2022$1,026,000
+17.9%
69,570
+5.8%
0.00%
Q4 2021$870,000
-31.9%
65,732
-10.2%
0.00%
Q3 2021$1,278,000
-37.7%
73,236
-14.5%
0.00%
Q2 2021$2,053,000
-27.7%
85,680
-22.5%
0.00%
-100.0%
Q1 2021$2,839,000
+229.7%
110,504
+143.8%
0.00%
Q4 2020$861,000
+62.8%
45,329
+7.7%
0.00%
Q3 2020$529,000
+3.5%
42,079
-0.2%
0.00%
Q2 2020$511,000
+90.7%
42,180
+20.3%
0.00%
Q1 2020$268,000
-57.0%
35,069
+0.2%
0.00%
Q4 2019$623,000
+45.6%
34,999
-5.1%
0.00%
Q3 2019$428,000
-50.5%
36,899
-5.6%
0.00%
Q2 2019$865,000
+324.0%
39,086
+448.3%
0.00%
Q1 2019$204,0007,1280.00%
Other shareholders
KALVISTA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Prosight Management, LP 589,270$8,686,0005.61%
GREAT POINT PARTNERS LLC 874,197$12,886,0003.11%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 383,233$10,805,0002.44%
Frazier Life Sciences Management, L.P. 1,572,192$23,174,0001.98%
TANG CAPITAL MANAGEMENT LLC 648,269$9,555,0001.91%
Deep Track Capital, LP 1,729,757$25,497,0001.64%
Vivo Capital, LLC 1,533,559$22,605,0001.56%
Monashee Investment Management LLC 264,111$3,893,0001.13%
COMMODORE CAPITAL LP 312,553$4,607,0001.03%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,746,300$25,740,0000.79%
View complete list of KALVISTA PHARMACEUTICALS INC shareholders